Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Understand factors that indicate long-term growth potential in crypto coins and how to select those with staying power.
27,742 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Jupiter, the Solana-based decentralized exchange, expands into tokenized IP by listing onchain Pokémon cards. The mov...
Coinbase’s latest metrics reveal retail traders are accumulating BTC and ETH despite volatility, while institutions d...
A senior executive at AtriCure recently sold 5,000 shares, prompting questions about what this insider move means for...
Marvell Technology rides AI tailwinds into a breakout, delivering record quarterly momentum and a growing pipeline of...
When a biotech CEO sells shares after exercising options, investors rightly pause to interpret the move. This article...
Regulators are advancing new crypto rules that could change trading, custody, and enforcement. This guide breaks down...
Tech leadership returns as Nvidia and Meta strengthen AI bets. This rally lifted major indexes and helped smaller gro...
The Federal Reserve left policy unchanged and raised its inflation forecast for 2026, shaking up expectations for cry...
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
Sequoia Capital partner Sean Maguire argues SpaceX sits at a pivotal point similar to Nvidia’s breakout years, and he...
The Trump administration presses more to accelerate domestic memory fabrication, aiming to reduce reliance on oversea...